VIA
NUVB icon

Virtus Investment Advisers’s Nuvation Bio NUVB Stock Holding History

Virtus Investment Advisers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
236,358
+136,207
+136% +$666K 0.31% 145
2026
Q1 		$430K Buy
100,151
+19,083
+24% +$106K 0.12% 237
2025
Q4 		$726K Buy
81,068
+18,202
+29% +$113K 0.2% 156
2025
Q3 		$233K Buy
62,866
+10,914
+21% +$29.7K 0.07% 246
2025
Q2 		$101K Sell
51,952
-10,469
-17% -$21.8K 0.03% 328
2025
Q1 		$110K Buy
+62,421
New +$142K 0.03% 407

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Virtus Investment Advisers's NUVB Position: Q2 2026 in Review

Virtus Investment Advisers increased its Nuvation Bio (NUVB) stake by 136% in Q2 2026, buying an estimated $666K and bringing the position to 236,358 shares worth $1.34M. The position accounts for 0.31% of the portfolio, ranked #145.

Virtus Investment Advisers first reported a position in NUVB in Q1 2025 and has held it in 6 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Virtus Investment Advisers held 236,358 shares of Nuvation Bio worth $1.34M as of Q2 2026.
  • Virtus Investment Advisers bought 136,207 Nuvation Bio shares in Q2 2026, an estimated $666K.
  • Nuvation Bio made up 0.31% of Virtus Investment Advisers's portfolio in Q2 2026, its #145 holding.
  • Virtus Investment Advisers first reported a position in Nuvation Bio in Q1 2025 and has held it in 6 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.